Effects of hormone therapy on body composition. Stults-Kolehmainen, M.A., & Sinha, R
Glycemic Control: By reducing liver glucose production and improving insulin sensitivity, it contributes to better control of blood sugar levels throughout the day
Tirzepatide holds FDA approvals as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic weight management (2023) and for moderate-to-severe obstructive sleep apnea (2024), and it is EMA-approved as well
However, not enough solid evidence supports its use for treating heart failure
As per FMI, the market's valuation is increasingly uncoupled from diabetes prevalence alone, driven by regulatory endorsement of weight management indications and cardiovascular risk reduction claims that expand the addressable patient population by an order of magnitude [1]
Each session uses pharmaceutical-grade, preservative-free formulas chosen based on your health goals and sensitivities